本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Zivo Bioscience, Inc.

2.40
-0.8000-25.00%
成交量:7,424.00
成交額:2.01萬
市值:960.02萬
市盈率:-1.06
高:3.05
開:3.05
低:2.36
收:3.20
52周最高:20.00
52周最低:2.36
股本:400.01萬
流通股本:276.73萬
量比:1.00
換手率:0.27%
股息:- -
股息率:- -
每股收益(TTM):-2.2747
每股收益(LYR):-5.5704
淨資產收益率:-3956.02%
總資產收益率:-1001.91%
市淨率:-2.92
市盈率(LYR):-0.43

資料載入中...

2024/06/13

重要事件披露

Form 8-K - Current report
2024/06/12

超過5%披露

Form SC 13D - General statement of acquisition of beneficial ownership
2024/06/12

超過5%披露

Form SC 13D - General statement of acquisition of beneficial ownership
2024/06/12

超過5%披露

Form SC 13D - General statement of acquisition of beneficial ownership
2024/06/07

超過5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2024/06/07

重要事件披露

Form 8-K/A - Current report: [Amend]
2024/06/06

重要事件披露

Form 8-K - Current report
2024/05/31

SEC問詢函

Form CORRESP - Correspondence
2024/05/13

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/04/09

超過5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2024/03/15

年度報告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2024/02/15

重要事件披露

Form 8-K - Current report
2024/02/15

交易所摘牌聲明

Form 25-NSE - Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities
2024/01/23

超過5%披露

Form SC 13D - General statement of acquisition of beneficial ownership
2024/01/17

重要事件披露

Form 8-K - Current report
2024/01/06

重要事件披露

Form 8-K - Current report
2024/01/04

重要事件披露

Form 8-K - Current report
2023/12/12

重要事件披露

Form 8-K - Current report
2023/11/27

重要事件披露

Form 8-K - Current report
2023/11/23

重要事件披露

Form 8-K - Current report